Sotera Health Co (SHC)

Sotera Health Company is a healthcare services provider focused on sterilization, laboratory testing, and advisory solutions for customers in the United States, Canada, Europe, and other international markets. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam technologies for medical devices, pharmaceuticals, food safety, and certain advanced applications. Nordion supplies Cobalt-60 used in sterilization and irradiation processes across medical device, pharmaceutical, food safety, and high-performance materials markets, and also provides gamma irradiation systems. Nelson Labs offers microbiological and analytical chemistry testing, along with advisory services, to medical device and pharmaceutical companies. Founded in 2015 and headquartered in Broadview Heights, Ohio, the company was formerly known as Sotera Health Topco, Inc. before adopting its current name in October 2020.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-SHC
$19.13
2.3% Upside
Fair
$22.72
21.6% Upside
Undervalued
Great
0.0%
November 10, 2026
32.6x
8.0x
4.4x
5.334 B
7.248 B
29.8%
64.9%
2.5
68.9%
Valuation • Fair Value

Sotera Health Co (NASDAQ-SHC) Fair Value by Valuation Model

Review the available estimates for Sotera Health Co (NASDAQ-SHC), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$19.13

Estimated upside of 2.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$19.70

Discounted cash flow valuation reference.

Ben Graham Formula Value

$6.36

Classic Ben Graham valuation formula reference.

Comps Fair Value

$18.55

Comparable-company valuation reference.

Analyst Price Target

$22.72

Analysts imply upside of 21.6%.

How to read these valuation models

Use the 6 available valuation references for Sotera Health Co (NASDAQ-SHC) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Sotera Health Co (NASDAQ-SHC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.216 B

Current operating scale indicator.

Revenue Forecast

1.246 B

Forward revenue estimate.

EBITDA

576.6 M

Current operating profitability reference.

EBITDA Forecast

639.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Sotera Health Co (NASDAQ-SHC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Sotera Health Co (NASDAQ-SHC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.49

No elevated caution signal from this screen.

Altman Z-Score

2.5

Intermediate risk zone.

FCF / Net Income

68.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Sotera Health Co (NASDAQ-SHC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Sotera Health Co (NASDAQ-SHC)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Sotera Health Co (NASDAQ-SHC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Sotera Health Co (NASDAQ-SHC) Stock Forecast & Technical Outlook

Review Sotera Health Co (NASDAQ-SHC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Sotera Health Co (NASDAQ-SHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Sotera Health Co (NASDAQ-SHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Sotera Health Co (NASDAQ-SHC) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Sotera Health Co (NASDAQ-SHC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Sotera Health Co (NASDAQ-SHC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Sotera Health Co (NASDAQ-SHC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Sotera Health Co (NASDAQ-SHC) has a Strong Buy consensus, with 5 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 2
Sell 0
FAQ Fast Investor Answers

Sotera Health Co (NASDAQ-SHC) Stock FAQ

Data-supported answers about Sotera Health Co (NASDAQ-SHC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$19.13
Estimated upside 2.3%
Valuation Rating
Undervalued
Estimated upside of 2.3%
Analyst Target
$22.72
Implied upside 21.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for Sotera Health Co (NASDAQ-SHC) is $19.13. This implies an estimated upside of 2.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 2.3% versus the current market price.

The available analyst price target for Sotera Health Co (NASDAQ-SHC) is $22.72. The analyst target implies estimated upside of 21.6%.

The current financial health read for Sotera Health Co (NASDAQ-SHC) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Sotera Health Co (NASDAQ-SHC) is November 10, 2026.

The latest available data indicates no current dividend yield for Sotera Health Co (NASDAQ-SHC).

The current P/E ratio listed for Sotera Health Co (NASDAQ-SHC) is 32.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Sotera Health Co is 5.334 B.

The current enterprise value listed for Sotera Health Co is 7.248 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Sotera Health Co is NASDAQ-SHC, and the stock is listed on NASDAQ.

Sotera Health Co (NASDAQ-SHC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Sotera Health Co is 29.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Sotera Health Co is 64.9%. Free float helps investors understand how much of the share base is available for public trading.